Alex Raut has over a decade of experience advising clients on transfer pricing matters.
Alex advises on the entire transfer pricing lifecycle – planning, implementation, documentation, and controversy – and has strong experience across a number of sectors, including pharmaceuticals and life sciences, software and technology, construction and engineering, and consumer goods.
He regularly assists clients in leveraging transfer pricing as a value driver, with significant experience in areas related to IP planning (including cost sharing arrangements, governance, and IP valuations), corporate restructurings, M&A, and financing and treasury operations. Alex has also led controversy and compliance projects, including MAPs, APAs, and OECD Local File / Master File documentation.
Advising an S&P 500 biotechnology company through a successful Ireland-UK Mutual Agreement Procedure following a UK Diverted Profits Tax review
Assisting a NASDAQ-listed pharmaceutical company with IP governance and operational guidelines supporting Irish substance and IP planning
Helping an S&P 500 food and beverage company with ongoing US transfer pricing litigation
Planning an IP migration to Ireland for a private equity backed software company following its acquisition of a European competitor
Working with an S&P 500 manufacturing company in seeking an Advance Pricing Agreement between Asian and European tax authorities following the design of a transfer pricing model for cross-border sales of goods
Designing and implementing a cost sharing arrangement for a European software-as-a-service company in the travel booking industry
Languages
English
French
Prior Experience
Ten years of Big 4 transfer pricing advisory experience
